Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.
3.

[PSA and follow-up after treatment of prostate cancer].

Benchikh El Fegoun A, Villers A, Moreau JL, Richaud P, Rebillard X, Beuzeboc P.

Prog Urol. 2008 Mar;18(3):137-44. doi: 10.1016/j.purol.2007.12.010. Epub 2008 Apr 18. Review. French.

PMID:
18472065
4.
5.

Markers and meaning of primary treatment failure.

Swindle PW, Kattan MW, Scardino PT.

Urol Clin North Am. 2003 May;30(2):377-401. Review.

PMID:
12735513
6.

Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?

Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon AL, Uzzo RG, Pollack A.

Cancer. 2005 Jul 15;104(2):299-304. Review.

7.

A systematic overview of radiation therapy effects in prostate cancer.

Nilsson S, Norlén BJ, Widmark A.

Acta Oncol. 2004;43(4):316-81. Review.

PMID:
15303499
8.
9.

Hormone therapy for patients with prostate carcinoma.

Klotz L.

Cancer. 2000 Jun 15;88(12 Suppl):3009-14. Review.

PMID:
10898345
10.

Hormonal therapy options for biochemical recurrence of prostate cancer after local therapy.

Moul JW.

Mol Urol. 2000 Fall;4(3):267-71;discussion 273. Review.

PMID:
11062383
11.

Progress in 3D conformal radiation treatment of prostate cancer.

Hanks GE.

Acta Oncol. 1999;38 Suppl 13:69-74. Review.

PMID:
10612499
12.

The utility of prostate-specific antigen in the management of advanced prostate cancer.

Crawford ED, Bennett CL, Andriole GL, Garnick MB, Petrylak DP.

BJU Int. 2013 Sep;112(5):548-60. doi: 10.1111/bju.12061. Epub 2013 Jul 4. Review.

13.
14.

Update on the treatment of prostate cancer with external beam irradiation.

Horwitz EM, Hanlon AL, Hanks GE.

Prostate. 1998 Nov 1;37(3):195-206. Review.

PMID:
9792138
15.

Immediate vs. delayed androgen deprivation for prostate cancer.

Van Cangh PJ, Gala JL, Tombal B.

Prostate Suppl. 2000;10:19-25. Review.

PMID:
11056489
16.

Focal therapy for prostate cancer 1996: maximizing outcome.

Carroll PR, Presti JC Jr, Small E, Roach M 3rd.

Urology. 1997 Mar;49(3A Suppl):84-94. Review.

PMID:
9123742
17.

[A coherent radiotherapeutic-surgical approach, based on PSA, for the management of cancer of the prostate].

Kagan AR, Zimmern PE, Hintz B, Himsl KK.

J Urol (Paris). 1994;100(4):173-84. Review. French.

PMID:
7532672
18.

Secondary hormonal manipulation of prostate cancer.

Harris KA, Small EJ.

Curr Urol Rep. 2001 Jun;2(3):224-30. Review.

PMID:
12084269
19.

Current controversies in the management of biochemical failure in prostate cancer.

Bruce JY, Lang JM, McNeel DG, Liu G.

Clin Adv Hematol Oncol. 2012 Nov;10(11):716-22. Review.

PMID:
23271258
20.

Expectant management with selective delayed intervention for favorable-risk prostate cancer.

Klotz LH, Choo R, Morton G, Danjoux C.

Can J Urol. 2002 Jun;9 Suppl 1:2-7. Review.

PMID:
12121587

Supplemental Content

Support Center